These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30077906)

  • 21. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
    Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
    Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ordered mesoporous platinum@graphitic carbon embedded nanophase as a highly active, stable, and methanol-tolerant oxygen reduction electrocatalyst.
    Wu Z; Lv Y; Xia Y; Webley PA; Zhao D
    J Am Chem Soc; 2012 Feb; 134(4):2236-45. PubMed ID: 22257228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein corona acts as a protective shield against Fe3O4-PEG inflammation and ROS-induced toxicity in human macrophages.
    Escamilla-Rivera V; Uribe-Ramírez M; González-Pozos S; Lozano O; Lucas S; De Vizcaya-Ruiz A
    Toxicol Lett; 2016 Jan; 240(1):172-84. PubMed ID: 26518974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of surface modification and size on oral drug delivery of mesoporous silica formulation.
    Wang Y; Cui Y; Zhao Y; Zhao Q; He B; Zhang Q; Wang S
    J Colloid Interface Sci; 2018 Mar; 513():736-747. PubMed ID: 29220688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
    Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
    Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma protein adsorption on Fe
    Escamilla-Rivera V; Solorio-Rodríguez A; Uribe-Ramírez M; Lozano O; Lucas S; Chagolla-López A; Winkler R; De Vizcaya-Ruiz A
    Int J Nanomedicine; 2019; 14():2055-2067. PubMed ID: 30988608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of water-soluble polymers, PEG and PVP, on the solubilisation of griseofulvin in aqueous micellar solutions of Pluronic F127.
    Oliveira CP; Ribeiro ME; Ricardo NM; Souza TV; Moura CL; Chaibundit C; Yeates SG; Nixon K; Attwood D
    Int J Pharm; 2011 Dec; 421(2):252-7. PubMed ID: 22001534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of structural differences in hyperbranched polyglycerol–polyethylene glycol nanoparticles on dermal drug delivery and biocompatibility.
    Kumar S; Alnasif N; Fleige E; Kurniasih I; Kral V; Haase A; Luch A; Weindl G; Haag R; Schäfer-Korting M; Hedtrich S
    Eur J Pharm Biopharm; 2014 Nov; 88(3):625-34. PubMed ID: 25445303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ordered mesoporous carbon nanoparticles with well-controlled morphologies from sphere to rod via a soft-template route.
    Li M; Xue J
    J Colloid Interface Sci; 2012 Jul; 377(1):169-75. PubMed ID: 22542324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of magnetic mesoporous silica nanoparticles as a multifunctional platform for potential drug delivery and hyperthermia.
    Yu X; Zhu Y
    Sci Technol Adv Mater; 2016; 17(1):229-238. PubMed ID: 27877873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PEGylated Carbon Nanocapsule: A Universal Reactor and Carrier for In Vivo Delivery of Hydrophobic and Hydrophilic Nanoparticles.
    Rammohan A; Mishra G; Mahaling B; Tayal L; Mukhopadhyay A; Gambhir S; Sharma A; Sivakumar S
    ACS Appl Mater Interfaces; 2016 Jan; 8(1):350-62. PubMed ID: 26646711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled synthesis of highly dispersed platinum nanoparticles in ordered mesoporous carbons.
    Liu SH; Lu RF; Huang SJ; Lo AY; Chien SH; Liu SB
    Chem Commun (Camb); 2006 Aug; (32):3435-7. PubMed ID: 16896486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of nitrogen-rich mesoporous carbon nitride with tunable pores, band gaps and nitrogen content from a single aminoguanidine precursor.
    Talapaneni SN; Mane GP; Mano A; Anand C; Dhawale DS; Mori T; Vinu A
    ChemSusChem; 2012 Apr; 5(4):700-8. PubMed ID: 22389323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity.
    Lin YS; Haynes CL
    J Am Chem Soc; 2010 Apr; 132(13):4834-42. PubMed ID: 20230032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved controlled release of protein from expanded-pore mesoporous silica nanoparticles modified with co-functionalized poly(n-isopropylacrylamide) and poly(ethylene glycol) (PNIPAM-PEG).
    Yu E; Lo A; Jiang L; Petkus B; Ileri Ercan N; Stroeve P
    Colloids Surf B Biointerfaces; 2017 Jan; 149():297-300. PubMed ID: 27776334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stealth nanocarriers based sterosomes using PEG post-insertion process.
    Cieślak A; Wauthoz N; Nieto Orellana A; Lautram N; Béjaud J; Hureaux J; Lafleur M; Benoit JP; Salomon CJ; Bastiat G
    Eur J Pharm Biopharm; 2017 Jun; 115():31-38. PubMed ID: 28216002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multi-controlled drug delivery system based on magnetic mesoporous Fe
    Zhang Q; Liu J; Yuan K; Zhang Z; Zhang X; Fang X
    Nanotechnology; 2017 Oct; 28(40):405101. PubMed ID: 28837053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers.
    Wang Y; Han N; Zhao Q; Bai L; Li J; Jiang T; Wang S
    Eur J Pharm Sci; 2015 May; 72():12-20. PubMed ID: 25701727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.